{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:14:36Z","timestamp":1790252076052,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001552","name":"Genesis Oncology Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001552","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lottery Health New Zealand"},{"DOI":"10.13039\/100008247","name":"University of Otago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12865-016-0178-4","type":"journal-article","created":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T13:27:10Z","timestamp":1476797230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Chitosan gel vaccine protects against tumour growth in an intracaecal mouse model of cancer by modulating systemic immune responses"],"prefix":"10.1186","volume":"17","author":[{"given":"Andrew J.","family":"Highton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Girardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia M.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Hook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roslyn A.","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,18]]},"reference":[{"key":"178_CR1","unstructured":"GLOBOCAN: GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. Lyon, France: International Agency for Research on Cancer and World Health Organization; 2012."},{"issue":"6","key":"178_CR2","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/S0016-5085(03)00376-7","volume":"124","author":"WM Grady","year":"2003","unstructured":"Grady WM. Genetic testing for high-risk colon cancer patients. Gastroenterol. 2003;124(6):1574\u201394.","journal-title":"Gastroenterol"},{"issue":"7","key":"178_CR3","first-page":"2727","volume":"29","author":"JK Triantafillidis","year":"2009","unstructured":"Triantafillidis JK, Nasioulas G, Kosmidis PA. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res. 2009;29(7):2727\u201337.","journal-title":"Anticancer Res"},{"issue":"5795","key":"178_CR4","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","volume":"313","author":"J Galon","year":"2006","unstructured":"Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313(5795):1960\u20134.","journal-title":"Science"},{"issue":"2","key":"178_CR5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12307-010-0052-5","volume":"4","author":"M Erreni","year":"2011","unstructured":"Erreni M, Mantovani A, Allavena P. Tumor-associated macrophages (TAM) and inflammation in colorectal cancer. Cancer Microenviron. 2011;4(2):141\u201354.","journal-title":"Cancer Microenviron"},{"issue":"11","key":"178_CR6","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1002\/ijc.24989","volume":"126","author":"DM Frey","year":"2010","unstructured":"Frey DM, Droeser RA, Viehl CT, Zlobec I, Lugli A, Zingg U, Oertli D, Kettelhack C, Terracciano L, Tornillo L. High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients. Int J Cancer. 2010;126(11):2635\u201343.","journal-title":"Int J Cancer"},{"issue":"7","key":"178_CR7","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00262-011-1046-y","volume":"60","author":"S Ladoire","year":"2011","unstructured":"Ladoire S, Martin F, Ghiringhelli F. Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer. Cancer Immunol Immunother. 2011;60(7):909\u201318.","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"178_CR8","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1053\/j.gastro.2009.06.053","volume":"137","author":"FA Sinicrope","year":"2009","unstructured":"Sinicrope FA, Rego RL, Ansell SM, Knutson KL, Foster NR, Sargent DJ. Intraepithelial effector (CD3+)\/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma. Gastroenterol. 2009;137(4):1270\u20139.","journal-title":"Gastroenterol"},{"issue":"2","key":"178_CR9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/sj.cgt.7700407","volume":"9","author":"T Endo","year":"2002","unstructured":"Endo T, Toda M, Watanabe M, Iizuka Y, Kubota T, Kitajima M, Kawakami Y. In situ cancer vaccination with a replication-conditional HSV for the treatment of liver metastasis of colon cancer. Cancer Gene Ther. 2002;9(2):142\u20138.","journal-title":"Cancer Gene Ther"},{"issue":"10","key":"178_CR10","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00384-013-1703-z","volume":"28","author":"J Kruse","year":"2013","unstructured":"Kruse J, von Bernstorff W, Evert K, Albers N, Hadlich S, Hagemann S, Gunther C, van Rooijen N, Heidecke CD, Partecke LI. Macrophages promote tumour growth and liver metastasis in an orthotopic syngeneic mouse model of colon cancer. Int J Colorectal Dis. 2013;28(10):1337\u201349.","journal-title":"Int J Colorectal Dis"},{"issue":"12","key":"178_CR11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028858","volume":"6","author":"E Zigmond","year":"2011","unstructured":"Zigmond E, Halpern Z, Elinav E, Brazowski E, Jung S, Varol C. Utilization of murine colonoscopy for orthotopic implantation of colorectal cancer. PLoS One. 2011;6(12), e28858.","journal-title":"PLoS One"},{"issue":"1","key":"178_CR12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/mt.2013.219","volume":"22","author":"C Devaud","year":"2014","unstructured":"Devaud C, Westwood JA, John LB, Flynn JK, Paquet-Fifield S, Duong CP, Yong CS, Pegram HJ, Stacker SA, Achen MG, et al. Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy. Mol Ther. 2014;22(1):18\u201327.","journal-title":"Mol Ther"},{"issue":"3","key":"178_CR13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ijc.21185","volume":"117","author":"H Alencar","year":"2005","unstructured":"Alencar H, King R, Funovics M, Stout C, Weissleder R, Mahmood U. A novel mouse model for segmental orthotopic colon cancer. Int J Cancer. 2005;117(3):335\u20139.","journal-title":"Int J Cancer"},{"issue":"1","key":"178_CR14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ijc.2910520118","volume":"52","author":"C Wilmanns","year":"1992","unstructured":"Wilmanns C, Fan D, O\u2019Brian CA, Bucana CD, Fidler IJ. Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5-fluorouracil. Int J Cancer. 1992;52(1):98\u2013104.","journal-title":"Int J Cancer"},{"issue":"7","key":"178_CR15","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/icb.2015.14","volume":"93","author":"AJ Highton","year":"2015","unstructured":"Highton AJ, Kojarunchitt T, Girardin A, Hook S, Kemp RA. Chitosan hydrogel vaccine generates protective CD8 T cell memory against mouse melanoma. Immunol Cell Biol. 2015;93(7):634\u201340.","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"178_CR16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0092-8674(94)90169-4","volume":"76","author":"KA Hogquist","year":"1994","unstructured":"Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T cell receptor antagonist peptides induce positive selection. Cell. 1994;76(1):17\u201327.","journal-title":"Cell"},{"key":"178_CR17","first-page":"484","volume":"10","author":"W Tseng","year":"2007","unstructured":"Tseng W, Leong X, Engleman E. Orthotopic mouse model of colorectal cancer. J Vis Exp. 2007;10:484.","journal-title":"J Vis Exp"},{"issue":"3","key":"178_CR18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0960-7404(92)90072-S","volume":"1","author":"H Kashtan","year":"1992","unstructured":"Kashtan H, Rabau M, Mullen JB, Wong AH, Roder JC, Shpitz B, Stern HS, Gallinger S. Intra-rectal injection of tumour cells: a novel animal model of rectal cancer. Surg Oncol. 1992;1(3):251\u20136.","journal-title":"Surg Oncol"},{"issue":"5","key":"178_CR19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.coi.2006.07.001","volume":"18","author":"E Treiner","year":"2006","unstructured":"Treiner E, Lantz O. CD1d- and MR1-restricted invariant T cells: of mice and men. Curr Opin Immunol. 2006;18(5):519\u201326.","journal-title":"Curr Opin Immunol"},{"issue":"7","key":"178_CR20","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.4049\/jimmunol.0901533","volume":"183","author":"JC Crispin","year":"2009","unstructured":"Crispin JC, Tsokos GC. Human TCR-alpha beta\u2009+\u2009CD4\u2013CD8- T cells can derive from CD8+ T cells and display an inflammatory effector phenotype. J Immunol. 2009;183(7):4675\u201381.","journal-title":"J Immunol"},{"issue":"6","key":"178_CR21","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1182\/blood-2006-04-016857","volume":"108","author":"E Buentke","year":"2006","unstructured":"Buentke E, Mathiot A, Tolaini M, Di Santo J, Zamoyska R, Seddon B. Do CD8 effector cells need IL-7R expression to become resting memory cells? Blood. 2006;108(6):1949\u201356.","journal-title":"Blood"},{"issue":"8","key":"178_CR22","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/ijc.27855","volume":"132","author":"A Girardin","year":"2013","unstructured":"Girardin A, McCall J, Black MA, Edwards F, Phillips V, Taylor ES, Reeve AE, Kemp RA. Inflammatory and regulatory T cells contribute to a unique immune microenvironment in tumor tissue of colorectal cancer patients. Int J Cancer. 2013;132(8):1842\u201350.","journal-title":"Int J Cancer"},{"issue":"4","key":"178_CR23","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T, Lafontaine L, Berger A, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39(4):782\u201395.","journal-title":"Immunity"},{"issue":"4","key":"178_CR24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bcp.2011.05.019","volume":"82","author":"F D\u2019Acquisto","year":"2011","unstructured":"D\u2019Acquisto F, Crompton T. CD3\u2009+\u2009CD4-CD8- (double negative) T cells: saviours or villains of the immune response? Biochem Pharmacol. 2011;82(4):333\u201340.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"178_CR25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/icb.2014.99","volume":"93","author":"MN Martina","year":"2015","unstructured":"Martina MN, Noel S, Saxena A, Rabb H, Hamad AR. Double negative (DN) alphabeta T cells: misperception and overdue recognition. Immunol Cell Biol. 2015;93(3):305\u201310.","journal-title":"Immunol Cell Biol"},{"issue":"2","key":"178_CR26","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0008-8749(90)90047-U","volume":"128","author":"A Bender","year":"1990","unstructured":"Bender A, Kabelitz D. CD4-CD8- human T cells: phenotypic heterogeneity and activation requirements of freshly isolated \u201cdouble-negative\u201d T cells. Cell Immunol. 1990;128(2):542\u201354.","journal-title":"Cell Immunol"},{"issue":"8","key":"178_CR27","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3324\/haematol.2011.041301","volume":"96","author":"I Bernardo","year":"2011","unstructured":"Bernardo I, Mancebo E, Aguilo I, Anel A, Allende LM, Guerra-Vales JM, Ruiz-Contreras J, Serrano A, Talayero P, de la Calle O, et al. Phenotypic and functional evaluation of CD3\u2009+\u2009CD4-CD8- T cells in human CD8 immunodeficiency. Haematologica. 2011;96(8):1195\u2013203.","journal-title":"Haematologica"},{"issue":"11","key":"178_CR28","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1084\/jem.20080039","volume":"205","author":"SI Hammerschmidt","year":"2008","unstructured":"Hammerschmidt SI, Ahrendt M, Bode U, Wahl B, Kremmer E, Forster R, Pabst O. Stromal mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo. J Exp Med. 2008;205(11):2483\u201390.","journal-title":"J Exp Med"},{"issue":"4","key":"178_CR29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2004.08.011","volume":"21","author":"M Iwata","year":"2004","unstructured":"Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. Retinoic acid imprints gut-homing specificity on T cells. Immunity. 2004;21(4):527\u201338.","journal-title":"Immunity"},{"issue":"6944","key":"178_CR30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature01726","volume":"424","author":"JR Mora","year":"2003","unstructured":"Mora JR, Bono MR, Manjunath N, Weninger W, Cavanagh LL, Rosemblatt M, Von Andrian UH. Selective imprinting of gut-homing T cells by Peyer\u2019s patch dendritic cells. Nature. 2003;424(6944):88\u201393.","journal-title":"Nature"},{"key":"178_CR31","first-page":"504","volume":"6","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Lakkis FG. Memory T cell migration. Front Immunol. 2015;6:504.","journal-title":"Front Immunol"},{"issue":"4","key":"178_CR32","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nm.3105","volume":"19","author":"Y Hailemichael","year":"2013","unstructured":"Hailemichael Y, Dai Z, Jaffarzad N, Ye Y, Medina MA, Huang XF, Dorta-Estremera SM, Greeley NR, Nitti G, Peng W, et al. Persistent antigen at vaccination sites induces tumor-specific CD8(+) T cell sequestration, dysfunction and deletion. Nat Med. 2013;19(4):465\u201372.","journal-title":"Nat Med"},{"issue":"21","key":"178_CR33","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0142-9612(00)00116-2","volume":"21","author":"A Chenite","year":"2000","unstructured":"Chenite A, Chaput C, Wang D, Combes C, Buschmann MD, Hoemann CD, Leroux JC, Atkinson BL, Binette F, Selmani A. Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials. 2000;21(21):2155\u201361.","journal-title":"Biomaterials"},{"key":"178_CR34","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.carbpol.2010.06.003","volume":"82","author":"X Tang YW","year":"2010","unstructured":"Tang YW X, Yan L, Lei M, Du Y, Kennedy JF, Knill CJ. Production and characterisation of novel injectable chitosan\/methylcellulose\/salt blend hydrogels with potential application as tissue engineering scaffolds. Carbohydr Polym. 2010;82:833\u201341.","journal-title":"Carbohydr Polym"},{"issue":"12","key":"178_CR35","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.vaccine.2009.01.091","volume":"27","author":"HX Sun","year":"2009","unstructured":"Sun HX, Xie Y, Ye YP. Advances in saponin-based adjuvants. Vaccine. 2009;27(12):1787\u201396.","journal-title":"Vaccine"},{"issue":"2","key":"178_CR36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/nat.2012.0340","volume":"22","author":"AM Krieg","year":"2012","unstructured":"Krieg AM. CpG still rocks! Update on an accidental drug. Nucleic Acid Ther. 2012;22(2):77\u201389.","journal-title":"Nucleic Acid Ther"},{"issue":"18","key":"178_CR37","doi-asserted-by":"crossref","first-page":"9730","DOI":"10.1073\/pnas.93.18.9730","volume":"93","author":"AY Huang","year":"1996","unstructured":"Huang AY, Gulden PH, Woods AS, Thomas MC, Tong CD, Wang W, Engelhard VH, Pasternack G, Cotter R, Hunt D, et al. The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product. Proc Natl Acad Sci U S A. 1996;93(18):9730\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"178_CR38","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1073\/pnas.0914879107","volume":"107","author":"KR Jordan","year":"2010","unstructured":"Jordan KR, McMahan RH, Kemmler CB, Kappler JW, Slansky JE. Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens. Proc Natl Acad Sci U S A. 2010;107(10):4652\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"178_CR39","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1084\/jem.20081752","volume":"205","author":"S Gilfillan","year":"2008","unstructured":"Gilfillan S, Chan CJ, Cella M, Haynes NM, Rapaport AS, Boles KS, Andrews DM, Smyth MJ, Colonna M. DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors. J Exp Med. 2008;205(13):2965\u201373.","journal-title":"J Exp Med"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-016-0178-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:46:52Z","timestamp":1718844412000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-016-0178-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,18]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["178"],"URL":"https:\/\/doi.org\/10.1186\/s12865-016-0178-4","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,18]]},"article-number":"39"}}